IPAR vs REGN
Inter Parfums Inc (IPAR) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Inter Parfums Inc (IPAR) is a household & personal products company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported IPAR revenue for 2023-12-31 was $1.32B. Net income was $187.8M. Revenue was up 21.3% from 2022-12-31 to 2023-12-31. IPAR currently screens at market cap $2.92B and trailing P/E 17.3.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
IPAR currently screens at market cap $2.92B and trailing P/E 17.3. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the IPAR and REGN stock pages for the full models.
Not investment advice.